Skip to main content
. 2020 Jul 2;22(8):822–830. doi: 10.1111/bdi.12959

Table 1.

Consensus on pharmacological strategy for Manic episodes

Manic episode in bipolar I Hypomanic episode in bipolar II Manic episode in elderly
Li + AAP 1st 1st 2nd
Li only 1st 1st 2nd
VAP + AAP 1st 2nd 2nd
VAP only 2nd 2nd 2nd
LTG + AAP 2nd No consensus No consensus
LTG only 3rd 3rd 3rd
CBZ only No consensus No consensus 3rd
OLZ only 2nd 2nd 2nd
ARP only 2nd 2nd 2nd
QTP only No consensus 2nd 2nd
RIS only No consensus No consensus 2nd
ASP only 2nd 2nd 3rd
Li + VAP 2nd 2nd No consensus
Li + LTG 2nd No consensus 2nd
VAP + LTG 3rd 3rd 3rd
Li + TAP No consensus n.a. n.a.
VAP + TAP No consensus n.a. n.a.
LTG + TAP 3rd n.a. n.a.
TAP only 3rd n.a. n.a.
Li + AD n.a. 3rd 3rd
VAP + AD n.a. 3rd 3rd
LTG + AD n.a. 3rd 3rd
AD only n.a. 3rd 3rd
MS + TH 3rd 3rd 3rd

Abbreviations: AD, antidepressant; AAP, atypical antipsychotic; ARP, aripiprazole; ASP, asenapine; CBZ, carbamazepine; CI, confidence interval; Li, lithium; LTG, lamotrigine; MS, mood stabilizer; n.a. = not available; OLZ, olanzapine; QTP, quetiapine; RIS, risperidone; SD, standard deviation; TAP, typical antipsychotic; TH, thyroid hormone; VAP, valproic acid.